Oncolytics (ONCY) meets primary endpoint for first part of US Phase 2 pancreatic cancer clinical trial
Tweet Send to a Friend
Oncolytics (Nasdaq: ONCY) meets ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
